Karmanos President & CEO

Gerold Bepler, M.D., Ph.D.
President and Chief Executive Officer

Gerold Bepler MD - President and CEOGerold Bepler, M.D., Ph.D., is a world-renowned thoracic oncologist who has spent his career researching risks, progression, treatments and outcomes related to lung cancer, with a special focus on non-small cell lung cancer.

Dr. Bepler began his tenure as president and chief executive officer of the Barbara Ann Karmanos Cancer Institute in Detroit in February 2010. He is credited with creating the Karmanos Cancer Network, Michigan’s largest cancer care and research network, with 16 locations throughout the state. Karmanos also is one of only 51 National Cancer Institute-designated, comprehensive cancer centers in the United States. In addition to his chief administrative duties, Dr. Bepler also serves as chair of the Department of Oncology at Wayne State University School of Medicine and is principal investigator of the National Cancer Institute Comprehensive Cancer Center Support Grant.

Prior to coming to Karmanos, Dr. Bepler was director of the Comprehensive Lung Cancer Research Center; department chair of Thoracic Oncology; and program leader of the Lung Cancer Program at the Moffitt Cancer Center in Tampa, FL. He also served as professor of Medicine and Oncology at the University of South Florida. Prior to joining the Moffitt Cancer Center, Dr. Bepler was director of the Lung Cancer Program at Roswell Park Cancer Institute in Buffalo, NY. He also held positions at Duke University Hospital and Durham VA Medical Center.

Dr. Bepler has secured more than $80 million in cancer-related research funding since the mid-1980s. He has published more than 200 peer-reviewed articles, including articles in the New England Journal of Medicine, the Journal of Clinical Oncology and Cancer Research. His awards and recognitions are numerous and include a three-year term on the Association of American Cancer Institutes Board of Directors (beginning October 2017); membership on the Women’s Choice Healthcare Advisory Board with WomenCertified Inc. (2014-present); an appointment to the Fleischner Society for Thoracic Imaging and Diagnosis (2012); the Moffitt Cancer Center’s Scientist of the Year (2008), the American College of Physicians Information and Education Resource Editorial Consultant (2007 – 2008), and he served on the Journal of Clinical Oncology Editorial Board (2006 – 2008). He also holds eight patents.

Dr. Bepler is a native of Germany. He received his medical and doctorate degrees from the Philipps University School of Medicine and Dentistry in Marburg, Germany. His postdoctoral fellowships were completed at the National Cancer Institute, Philipps University and at Duke University Medical Center.

The Latest From Karmanos Cancer Institute

News

100th proton therapy patient says he’s glad he chose Karmanos and McLaren in Flint

The Karmanos Cancer Institute at McLaren Flint and the McLaren Proton Therapy Center offers Genesee County cancer patients the best chance in beat...

Read More

McLaren Names Kimberly Keaton Williams Chief Diversity Officer

McLaren Health Care has appointed Kimberly Keaton Williams to serve as Chief Diversity Officer for the health system. Keaton Williams currently se...

Read More

Kamiar Moin, Ph.D., secures prestigious R50 grant from the National Cancer Institute

Kamiar Moin, Ph.D., director of the Microscopy, Imaging & Cytometry Resources (MICR) Core at the Barbara Ann Karmanos Cancer Institute and pro...

Read More